Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Volpe

Showing results (231-240 of 820) with videos related to

Pageof 82
Sort By:
Giornale Italiano Di Cardiologia (2006)|July 12, 2012
[Polytherapy in cardiovascular prevention: open issues]Massimo Volpe, Giulia Pignatelli, Francesco Paneni
European Heart Journal|April 15, 2024
Obesity: an overlooked player in cardiological practice and the need for urgent actionArmando Ferrera, Allegra Battistoni, Massimo Volpe
Journal of Hypertension|March 18, 2003
Do COX-2 inhibitors really prevent hypertension and proteinuria? Another brick in the wall for the COX-2 inhibition and cardiovascular disease controversyFrancesco Cosentino, Pietro Francia, Massimo Volpe
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|September 29, 2011
Direct renin inhibition: from pharmacological innovation to novel therapeutic opportunitiesMassimo Volpe, Roberto Pontremoli, Claudio Borghi
Journal of Molecular Medicine (Berlin, Germany)|August 10, 2011
Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptidesCamilla Calvieri, Speranza Rubattu, Massimo Volpe
Circulation Research|October 30, 2016
Angiotensin II-Linked Hypothesis to Understand the Advantage of the Coevolution of Hypertension and Malaria: "Sympathy for the Devil"Massimo Volpe, Allegra Battistoni, Giuseppe Mancia
Hypertension (Dallas, Tex. : 1979)|November 10, 2021
Novel ANP (Atrial Natriuretic Peptide)-Based Therapy for Hypertension: The Promising Role of a Disease Mechanism Targeted ApproachMassimo Volpe, Giovanna Gallo, Speranza Rubattu
Circulation Research|February 1, 2014
Mammalian target of rapamycin signaling in cardiac physiology and diseaseSebastiano Sciarretta, Massimo Volpe, Junichi Sadoshima
Journal of Hypertension|June 14, 2008
Development of heart failure in recent hypertension trialsGiuliano Tocci, Sebastiano Sciarretta, Massimo Volpe
Journal of the American Society of Nephrology : JASN|March 28, 2006
Fewer mega-trials and more clinically oriented studies in hypertension research? The case of blocking the renin-angiotensin-aldosterone systemMassimo Volpe, Giuliano Tocci, Erika Pagannone
Pageof 82

Showing results (231-240 of 820) with videos related to

Sort By:
Pageof 82
Giornale Italiano Di Cardiologia (2006)|July 12, 2012
[Polytherapy in cardiovascular prevention: open issues]Massimo Volpe, Giulia Pignatelli, Francesco Paneni
European Heart Journal|April 15, 2024
Obesity: an overlooked player in cardiological practice and the need for urgent actionArmando Ferrera, Allegra Battistoni, Massimo Volpe
Journal of Hypertension|March 18, 2003
Do COX-2 inhibitors really prevent hypertension and proteinuria? Another brick in the wall for the COX-2 inhibition and cardiovascular disease controversyFrancesco Cosentino, Pietro Francia, Massimo Volpe
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|September 29, 2011
Direct renin inhibition: from pharmacological innovation to novel therapeutic opportunitiesMassimo Volpe, Roberto Pontremoli, Claudio Borghi
Journal of Molecular Medicine (Berlin, Germany)|August 10, 2011
Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptidesCamilla Calvieri, Speranza Rubattu, Massimo Volpe
Circulation Research|October 30, 2016
Angiotensin II-Linked Hypothesis to Understand the Advantage of the Coevolution of Hypertension and Malaria: "Sympathy for the Devil"Massimo Volpe, Allegra Battistoni, Giuseppe Mancia
Hypertension (Dallas, Tex. : 1979)|November 10, 2021
Novel ANP (Atrial Natriuretic Peptide)-Based Therapy for Hypertension: The Promising Role of a Disease Mechanism Targeted ApproachMassimo Volpe, Giovanna Gallo, Speranza Rubattu
Circulation Research|February 1, 2014
Mammalian target of rapamycin signaling in cardiac physiology and diseaseSebastiano Sciarretta, Massimo Volpe, Junichi Sadoshima
Journal of Hypertension|June 14, 2008
Development of heart failure in recent hypertension trialsGiuliano Tocci, Sebastiano Sciarretta, Massimo Volpe
Journal of the American Society of Nephrology : JASN|March 28, 2006
Fewer mega-trials and more clinically oriented studies in hypertension research? The case of blocking the renin-angiotensin-aldosterone systemMassimo Volpe, Giuliano Tocci, Erika Pagannone
Pageof 82